These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1520872)

  • 21. Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4.
    Moore JP; McKeating JA; Jones IM; Stephens PE; Clements G; Thomson S; Weiss RA
    AIDS; 1990 Apr; 4(4):307-15. PubMed ID: 2190605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human immunodeficiency virus type 1 envelope glycoprotein gp120-mediated killing of human haematopoietic progenitors (CD34+ cells).
    Zauli G; Re MC; Furlini G; Giovannini M; La Placa M
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():417-21. PubMed ID: 1371543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.
    Neurath AR; Strick N; Li YY; Jiang S
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1195-208. PubMed ID: 8142138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response.
    Bolmstedt A; Sjölander S; Hansen JE; Akerblom L; Hemming A; Hu SL; Morein B; Olofsson S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jul; 12(3):213-20. PubMed ID: 8673525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The difference in gp160 and gp120 of HIV type 1 in the induction of CD4 downregulation preceding single-cell killing.
    Koga Y; Nakamura K; Sasaki M; Kimura G; Nomoto K
    Virology; 1994 May; 201(1):137-41. PubMed ID: 8178478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signals transduced through the CD4 molecule on T lymphocytes activate NF-kappa B.
    Chirmule N; Kalyanaraman VS; Pahwa S
    Biochem Biophys Res Commun; 1994 Aug; 203(1):498-505. PubMed ID: 7915519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes.
    Willey RL; Maldarelli F; Martin MA; Strebel K
    J Virol; 1992 Jan; 66(1):226-34. PubMed ID: 1727486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network.
    Montefiori DC; Graham BS; Zhou J; Zhou J; Bucco RA; Schwartz DH; Cavacini LA; Posner MR
    J Clin Invest; 1993 Aug; 92(2):840-7. PubMed ID: 8349820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
    Fenouillet E; Miquelis R; Drillien R
    Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible mechanisms accounting for the growth factor independence of hematopoietic progenitors from umbilical cord blood.
    Schibler KR; Li Y; Ohls RK; Nye NC; Durham MC; White W; Liechty KW; Le T; Christensen RD
    Blood; 1994 Dec; 84(11):3679-84. PubMed ID: 7524747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stable expression of the human immunodeficiency virus type 1 envelope glycoprotein in transfected L cells.
    Bird C; Gleeson PA; Ramsay A; Li P; McCluskey J
    AIDS Res Hum Retroviruses; 1992 Dec; 8(12):1999-2009. PubMed ID: 1493050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human immunodeficiency virus-1 gp120 and gp160 envelope proteins modulate mesangial cell gelatinolytic activity.
    Singhal PC; Sagar S; Chandra D; Garg P
    Am J Pathol; 1995 Jul; 147(1):25-32. PubMed ID: 7604883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved cell-mediated immune responses in HIV-1-infected asymptomatic individuals after immunization with envelope glycoprotein gp160.
    Wahren B; Bratt G; Persson C; Levén B; Hinkula J; Gilljam G; Nordlund S; Eriksson L; Volvovitz F; Broliden PA
    J Acquir Immune Defic Syndr (1988); 1994 Mar; 7(3):220-9. PubMed ID: 7906300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of HIV-1 envelope glycoproteins by Semliki Forest virus vectors.
    Paul NL; Marsh M; McKeating JA; Schulz TF; Liljeström P; Garoff H; Weiss RA
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):963-70. PubMed ID: 8280479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity.
    Page KA; Stearns SM; Littman DR
    J Virol; 1992 Jan; 66(1):524-33. PubMed ID: 1727497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure.
    Poumbourios P; el Ahmar W; McPhee DA; Kemp BE
    J Virol; 1995 Feb; 69(2):1209-18. PubMed ID: 7815497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kex2p: a model for cellular endoprotease processing human immunodeficiency virus type 1 envelope glycoprotein precursor.
    Moulard M; Achstetter T; Kieny MP; Montagnier L; Bahraoui E
    Eur J Biochem; 1994 Oct; 225(2):565-72. PubMed ID: 7957171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium requirement and inhibitor spectrum for intracellular HIV type 1 gp160 processing in cultured HeLa cells and CD4+ lymphocytes: similarity to those of viral envelope glycoprotein maturase.
    Kamoshita K; Shiota M; Sasaki M; Koga Y; Okumura Y; Kido H
    J Biochem; 1995 Jun; 117(6):1244-53. PubMed ID: 7490267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AIDS pathogenesis: HIV envelope and its interaction with cell proteins.
    Habeshaw JA; Dalgleish AG; Bountiff L; Newell AL; Wilks D; Walker LC; Manca F
    Immunol Today; 1990 Nov; 11(11):418-25. PubMed ID: 2078296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients.
    Oh SK; Cruikshank WW; Raina J; Blanchard GC; Adler WH; Walker J; Kornfeld H
    J Acquir Immune Defic Syndr (1988); 1992; 5(3):251-6. PubMed ID: 1740750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.